LESLIE HUGHES: Open Payments
NPI 1598381261 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,288 in 175 payments from 16 companies in 2025. Trend: 2023 $2,180 · 2024 $2,273 · 2025 $3,288
Food & beverage: $3,186Education: $101
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 25 | $439 |
| Janssen Pharmaceuticals, Inc | 18 | $404 |
| Alkermes, Inc. | 19 | $306 |
| Otsuka America Pharmaceutical, Inc. | 19 | $303 |
| E.R. Squibb & Sons, L.L.C. | 10 | $283 |
| ABBVIE INC. | 22 | $271 |
| Vanda Pharmaceuticals Inc. | 12 | $220 |
| Axsome Therapeutics, Inc. | 12 | $206 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $203 |
| Corium, LLC | 9 | $201 |
Products named: INGREZZA, ARISTADA, COBENFY, VRAYLAR, REXULTI, FANAPT, SPRAVATO, Auvelity.
Industry payments across LA — which companies pay providers there.
